These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24120098)

  • 1. [Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment].
    Reus Bañuls S; Portilla Sogorb J; Sanchez-Paya J; Boix Martínez V; Giner Oncina L; Frances R; Such J; Merino Lucas E; Gimeno Gascón A
    Med Clin (Barc); 2014 Jan; 142(2):47-52. PubMed ID: 24120098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-level HIV viremia is associated with microbial translocation and inflammation.
    Reus S; Portilla J; Sánchez-Payá J; Giner L; Francés R; Such J; Boix V; Merino E; Gimeno A
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):129-34. PubMed ID: 23018379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is it posible to reduce the human immunodeficiency virus-associated chronic inflammation?].
    Rocafort M; Paredes R
    Med Clin (Barc); 2014 Jan; 142(2):64-6. PubMed ID: 24216015
    [No Abstract]   [Full Text] [Related]  

  • 5. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
    J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
    Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
    Jiang W; Lederman MM; Hunt P; Sieg SF; Haley K; Rodriguez B; Landay A; Martin J; Sinclair E; Asher AI; Deeks SG; Douek DC; Brenchley JM
    J Infect Dis; 2009 Apr; 199(8):1177-85. PubMed ID: 19265479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
    Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
    J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
    Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
    J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients.
    García-Álvarez M; Berenguer J; Jiménez-Sousa MÁ; Vázquez-Morón S; Carrero A; Gutiérrez-Rivas M; Aldámiz-Echevarría T; López JC; García-Broncano P; Resino S
    AIDS; 2016 Apr; 30(7):1069-74. PubMed ID: 27032111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden.
    Missailidis C; Höijer J; Johansson M; Ekström L; Bratt G; Hejdeman B; Bergman P
    Scand J Immunol; 2015 Jul; 82(1):55-62. PubMed ID: 25833795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.
    Pilakka-Kanthikeel S; Huang S; Fenton T; Borkowsky W; Cunningham CK; Pahwa S
    Pediatr Infect Dis J; 2012 Jun; 31(6):583-91. PubMed ID: 22333700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals.
    Lacerda HR; Falcão Mda C; de Albuquerque VM; Zírpoli JC; Miranda-Filho Dde B; de Albuquerque Mde F; Montarroyos U; Ximenes RA
    J Interferon Cytokine Res; 2014 May; 34(5):385-93. PubMed ID: 24359573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical atherosclerosis in low Framingham risk HIV patients.
    León R; Reus S; López N; Portilla I; Sánchez-Payá J; Giner L; Boix V; Merino E; Torrús D; Moreno-Pérez Ó; Portilla J
    Eur J Clin Invest; 2017 Aug; 47(8):591-599. PubMed ID: 28664622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity.
    López-Calderón C; Palacios R; Cobo A; Nuño E; Ruiz J; Márquez M; Santos J
    Int J STD AIDS; 2015 May; 26(6):393-7. PubMed ID: 24912540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.